| 1 |
Liu H, Xu C, Hu Q, et al. Sepsis-induced cardiomyopathy: understanding pathophysiology and clinical implications[J]. Arch Toxicol, 2025, 99 (2): 467-480.
|
| 2 |
Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395 (10219): 200-211.
|
| 3 |
Zhang H, Liu D. Sepsis-related cardiomyopathy: not an easy task for ICU physicians[J]. J Intensive Med, 2022, 2 (4): 257-259.
|
| 4 |
刘峰宇，孙同文.脓毒症心肌病的诊疗进展[J].中华急诊医学杂志，2022，31（7）：858-861.
|
| 5 |
Yalta K, Madias JE, Kounis NG, et al. Takotsubo syndrome: an international expert consensus report on practical challenges and specific conditions (Part-1: diagnostic and therapeutic challenges)[J]. Balkan Med J, 2024, 41 (6): 421-441.
|
| 6 |
Cammann VL, Würdinger M, Ghadri JR, et al. Takotsubo syndrome: uncovering myths and misconceptions[J]. Curr Atheroscler Rep, 2021, 23 (9): 53.
|
| 7 |
张宏民，周高生，张青，等.脓毒症相关心肌病患者危险因素及预后分析[J].中华内科杂志，2022，61（6）：644-651.
|
| 8 |
Schweiger V, Di Vece D, Cammann VL, et al. Cardiac biomarkers for diagnosing Takotsubo syndrome[J]. Eur Heart J, 2024, 45 (25): 2254-2258.
|
| 9 |
李志宇，崔少华，耿立霞.生物标志物联合检测对脓毒性心肌损伤患者早期诊断及预后评估的价值[J].中华危重病急救医学，2021，33（4）：443-448.
|
| 10 |
陈怡慧，董鹏，张喜洋.促炎细胞因子在脓毒症中作用的研究进展[J].中华危重病急救医学，2023，35（2）：212-216.
|
| 11 |
Retnoningrum D, Mulyono B, Intansari US, et al. Interleukin-17 as predictor mortality of septic patients: a systematic review and meta-analysis[J]. Wiad Lek, 2024, 77 (6): 1134-1140.
|
| 12 |
Póvoa P, Coelho L, Dal-Pizzol F, et al. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians[J]. Intensive Care Med, 2023, 49 (2): 142-153.
|
| 13 |
王婵，董道然，荆程桥，等.心型脂肪酸结合蛋白对脓毒性心肌病的早期诊断价值[J].中国急救医学，2023，43（3）：169-174.
|
| 14 |
商娜，郭树彬，刘慧珍，等.脓毒症心肌病患者组蛋白H4的变化及预测价值[J].中华急诊医学杂志，2022，31（2）：197-202.
|
| 15 |
Hu P, Lu YH, Deng W, et al. The critical role of pancreatic stone protein/regenerating protein in sepsis-related multiorgan failure[J]. Front Med (Lausanne), 2023, 10: 1172529.
|
| 16 |
Vetrugno L, Biasucci DG. Diastolic dysfunction in septic patients: an alice-in-wonderland perspective on mortality impact[J]. Intensive Care Med, 2025, 51 (5): 968-969.
|
| 17 |
Mukherjee M, Rudski LG, Addetia K, et al. Guidelines for the echocardiographic assessment of the right heart in adults and special considerations in pulmonary hypertension: recommendations from the American Society of Echocardiography[J]. J Am Soc Echocardiogr, 2025, 38 (3): 141-186.
|
| 18 |
欧艳，李芳，刘利. M-BLUE对于急性呼吸衰竭鉴别及病因诊断中的价值[J].临床肺科杂志，2020，25（6）：857-861.
|
| 19 |
傅萱.二维斑点追踪成像超声心动图在急诊脓毒症心肌病患者中的应用研究[D].北京：中国医学科学院、清华大学医学部、北京协和医学院，2022.
|
| 20 |
许崇俊，余承芳，沈红梅，等.心脏超声造影鉴别右心占位病变的临床应用价值[J].中国循环杂志，2024，39（5）：490-494.
|
| 21 |
Vidal-Perez R, Brandao M, Zaher W, et al. Value of cardiac magnetic resonance on the risk stratification of cardiomyopathies[J]. World J Cardiol, 2023, 15 (10): 487-499.
|
| 22 |
Loh YH, Hong XL. Bridging the gap in cardiac mass diagnosis: advanced imaging, genetic associations, and biomarkers[J]. World J Clin Cases, 2024, 12 (22): 4859-4864.
|
| 23 |
Lange T, Backhaus SJ, Schulz A, et al. Cardiovascular magnetic resonance-derived left atrioventricular coupling index and major adverse cardiac events in patients following acute myocardial infarction[J]. J Cardiovasc Magn Reson, 2023, 25 (1): 24.
|
| 24 |
Singh T, Khan H, Gamble DT, et al. Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications[J]. Circulation, 2022, 145 (13): 1002-1019.
|
| 25 |
Shime N, Nakada TA, Yatabe T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2024[J]. J Intensive Care, 2025, 13 (1): 15.
|
| 26 |
Al-Sunaidar KA, Prof Abd Aziz N, Prof Hassan Y. Appropriateness of empirical antibiotics: risk factors of adult patients with sepsis in the ICU[J]. Int J Clin Pharm, 2020, 42 (2): 527-538.
|
| 27 |
田威威，李月明.脓毒症感染患者抗生素治疗策略分析[J].中华保健医学杂志，2022，24（5）：419-421.
|
| 28 |
Nayak R, Chiu S, Schweis F, et al. Cardiogenic shock and respiratory failure complicating takotsubo syndrome[J]. J Invasive Cardiol, 2022, 34 (4): E274-E280.
|
| 29 |
Ruslan MA, Baharuddin KA, Noor NM, et al. Norepinephrine in septic shock: a systematic review and meta-analysis[J]. West J Emerg Med, 2021, 22 (2): 196-203.
|
| 30 |
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47 (11): 1181-1247.
|
| 31 |
Law AC, Bosch NA, Peterson D, et al. Comparison of heart rate after phenylephrine vs norepinephrine initiation in patients with septic shock and atrial fibrillation[J]. Chest, 2022, 162 (4): 796-803.
|
| 32 |
Kakihana Y, Nishida O, Taniguchi T, et al. Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial[J]. Lancet Respir Med, 2020, 8 (9): 863-872.
|
| 33 |
王俊义，何正中，高心晶，等.左室内压最大上升速率评价脓毒性心肌病患者心功能变化的价值[J].中华危重病急救医学，2023，35（6）：620-626.
|
| 34 |
Gendreau S, Frapard T, Carteaux G, et al. Geo-economic influence on the effect of fluid volume for sepsis resuscitation: a meta-analysis[J]. Am J Respir Crit Care Med, 2024, 209 (5): 517-528.
|
| 35 |
姚浩旗，邵慧娟，刘静霞，等.重症监护病房脓毒症患者短期生存调查和死亡危险因素分析[J].中华危重病急救医学，2023，35（10）：1039-1044.
|
| 36 |
中华医学会心血管病学分会，中国医师协会心血管内科医师分会，中国医师协会心力衰竭专业委员会，等.中国心力衰竭诊断和治疗指南2024[J].中华心血管病杂志，2024，52（3）：235-275.
|
| 37 |
Yagnik K, Mohan G, Ketkar A, et al. Factors affecting continuous renal replacement therapy (CRRT) in patients with septic shock: an analysis of a national inpatient sample database[J]. Cureus, 2024, 16 (11): e74356.
|
| 38 |
李丽丽，吴晨晨，闫艳玲.连续性肾脏替代治疗联合血液灌流对脓毒症患者临床疗效的影响[J].中国中西医结合急救杂志，2023，30（3）：304-307.
|
| 39 |
Epstein D, Badarni K, Bar-Lavie Y. Impact of haemoadsorption therapy on short term mortality and vasopressor dependency in severe septic shock with acute kidney injury: a retrospective cohort study[J]. Antibiotics (Basel), 2024, 13 (12): 1233.
|
| 40 |
Lüsebrink E, Binzenhofer L, Kellnar A, et al. Venting during venoarterial extracorporeal membrane oxygenation[J]. Clin Res Cardiol, 2023, 112 (4): 464-505.
|
| 41 |
Ravikumar N, Sayed MA, Poonsuph CJ, et al. Septic cardiomyopathy: from basics to management choices[J]. Curr Probl Cardiol, 2021, 46 (4): 100767.
|
| 42 |
Kuno T, Takagi H, Ando T, et al. Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: insights from a network meta-analysis of randomized trials[J]. Catheter Cardiovasc Interv, 2021, 97 (5): E636-E645.
|
| 43 |
中国急诊ECMO科研协作组，中华医学会急诊医学分会生命支持学组.成人体外心肺复苏经皮穿刺置管中国急诊专家共识[J].中国急救医学，2023，43（8）：597-604.
|
| 44 |
苏用鹏，卢剑海，朱瑞秋，等.体外膜氧合辅助心肺复苏患者50例置管经验总结[J].中国体外循环杂志，2020，18（2）：95-97.
|
| 45 |
徐静，高敏，王露平，等.体外心肺复苏患者术后早期脉压损失是ECMO撤机失败的独立预测因素[J].中华危重病急救医学，2023，35（5）：498-502.
|
| 46 |
李乐，刘尚雨，吴灵敏，等.复杂室性心律失常合并心肌炎患者的临床特点与心内膜心肌活检的诊断价值[J].中国循环杂志，2023，38（6）：669-674.
|
| 47 |
刘谱秀，龚园其.单细胞转录组测序在脓毒症中的研究进展[J/OL].中华危重症医学杂志（电子版），2025，18（4）：333-336.
|